Fate Therapeutics Inc. Alternatives & Competitors
12 companies similar to Fate Therapeutics Inc. — Transforming the lives of patients with autoimmune diseases and cancer.
Companies similar to Fate Therapeutics Inc.
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine lea...
Cambridge, United States
Minerva Biotechnologies
We see the future first
Waltham, United States
Rival Readout
Competing with Fate Therapeutics Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
StemSight - Vision Unlimited
Curing blindness with regenerative cell therapies.
Tampere, Finland
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Angiocrine Bioscience, Inc.
Transforming medicine through engineered cellular therapies that restore, regenerate, and...
San Diego, United States
TScan Therapeutics
Unleash Immunity
Waltham, United States
Altheia Science
Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...
Milano, Italy
MedXCell SA
The Cell Therapy Venture Builder
Montreux, Switzerland
About Fate Therapeutics Inc.
Fate Therapeutics Inc., founded in 2007 and headquartered in the United States, is a clinical-stage biopharmaceutical leader with a compelling mission of "Transforming the lives of patients with autoimmune diseases and cancer." The company excels in the Biotechnology sector, offering innovative induced pluripotent stem...
Research and Development, Cell Therapy Development, Clinical Trials Management, Biopharmaceutical Manufacturing
Patients with Autoimmune Diseases, Cancer Patients, Healthcare Providers, Biomedical Researchers
IPSC-derived Cellular Immunotherapies, Stem Cell Therapeutics, Immuno-oncology, Autoimmune Diseases, Master IPSC Lines, Off-the-shelf Cell Products, NK Cell Product Candidates, T-cell Product Candidates, Synthetic Controls Of Cell Function, Multiplexed-engineered, Clinical-stage Biopharmaceutical, Cellular Immunotherapies, Regenerative Therapies, Stem Cell Modulators, Hematopoietic Progenitor Cells
B2B, B2C, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Fate Therapeutics Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Fate Therapeutics Inc. on 3 Jul 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
